Age (years)/ Gender | INR <1.4 | INTEM-CT (sec) | EXTEM-CT (sec) | FIBTEM-MCF (mm) | Platelet count (×109/ L) | WBCT20 | AVS | Summary | Clinical syndrome |
---|---|---|---|---|---|---|---|---|---|
70/F | 1.04 | 119 | 58 | 15 | 275 | Clotted | Not given | Clotted WBCT20 and normal ROTEM | AKI, NS+, LE+ |
65/ M | 0.97 | 171 | 64 | 12 | 135 | AKI, NS+, LE+ | |||
58/ M | 1.13 | 225 | 61 | 16 | 226 | NS+, LE+ | |||
33/ M | 1.01 | 155 | 69 | 16 | - | NS+, LE+ | |||
13/ M | 1.14 | 170 | 61 | 10 | - | NS+, LE+ | |||
63/ M | 0.906 | 187 | 55 | 10 | 183 | NS+, LE+ | |||
34/ M | 1.03 | 143 | 50 | 12 | 322 | NS+, LE+ | |||
59/ M | 1.15 | 170 | 77 | 13 | - | NS+, LE+ | |||
57/ F | 1.07 | 129 | 56 | 19 | - | NS+, LE+ | |||
37/ F | 0.99 | 185 | 79 | 14 | 263 | NS+, LE+ | |||
56/ M | 4.88 ↑ | 165 | 97 ↑ | 18 | 221 | Clotted | Not given | Clotted WBCT20 and abnormal ROTEM. | NS+, LE+ |
50/ M | 1.16 | 177 | 90 ↑ | 11 | 239 | NS+, LE+ | |||
40/ M | 1.06 | 130 | 102 ↑ | 10 | 223 | NS+, LE+ | |||
40/ M | 1.00 | 178 | 83 ↑ | 24 | - | NS+, LE+ | |||
48/ M | 1.4 | 151 | 83 ↑ | 12 | 288 | NS+, LE+ | |||
50/ M | 0.91 | 257 ↑ | 64 | 10 | 194 | AKI, NS+, LE+ | |||
57/ M | 0.963 | 2510 ↑ | 66 | 13 | 150 | NS+, LE+ | |||
31/ M | 1.14 | 389 ↑ | 77 | 10 | 264 | NS+, LE+ | |||
15/ M | 1.17 | 347 ↑ | 73 | 17 | 267 | NS+, LE+ | |||
52/ M | 1.00 | 263 ↑ | 54 | 17 | 19 ↓ | Given | AKI, NS+, LE+ | ||
40/M | 1.79 ↑ | 312 ↑ | 2285 ↑ | 3 ↓ | 122 ↓ | NS+, LE+ | |||
29/ M | 1.06 | 109 | 65 | 9 | 259 | Non-clotted | Not given | Non-clotted WBCT20 and normal ROTEM | NS+, LE+ |
59/M | 1.03 | 240 | 70 | 7 | 130 | NS+, LE+ |